These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7813167

  • 1. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients.
    Fiorini F, Patrone E, Castelluccio A.
    Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167
    [Abstract] [Full Text] [Related]

  • 2. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Sep; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 3. [Dyslipidemia in the uremic patient: the therapeutic role played by simvastatin].
    Bellinghieri G, Angelé B, Savica V.
    Clin Ter; 1992 Jan; 140(1 Pt 2):11-6. PubMed ID: 1559316
    [Abstract] [Full Text] [Related]

  • 4. Low-dose simvastatin is safe in hyperlipidaemic renal transplant patients.
    Martinez Hernandez BE, Persaud JW, Varghese Z, Moorhead JF.
    Nephrol Dial Transplant; 1993 Jan; 8(7):637-41. PubMed ID: 8396749
    [Abstract] [Full Text] [Related]

  • 5. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 6. The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemia.
    Hoogerbrugge N, Jansen H, De Heide L, Zillikens MC, Deckers JW, Birkenhäger JC.
    J Intern Med; 1997 Feb; 241(2):151-5. PubMed ID: 9077372
    [Abstract] [Full Text] [Related]

  • 7. The effect of simvastatin on HDL cholesterol in hyperlipidemic patients. Evidence of a relationship with the changes in serum triglyceride level.
    Branchi A, Rovellini A, Fiorenza AM, Maraffi F, Gandini R, Sommariva D.
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):384-9. PubMed ID: 8880287
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

  • 9. [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk].
    Strano A, Novo S, Notarbartolo A, Davì G, Abrignani MG, Alaimo G, Averna MR, Barbagallo CM, Marino G.
    Cardiologia; 1989 Dec; 34(12):1027-33. PubMed ID: 2634479
    [Abstract] [Full Text] [Related]

  • 10. Post-marketing surveillance of probucol (Sinlestal) in Japan.
    Kosasayama A, Yoshida M, Okada S.
    Artery; 1992 Dec; 19(3):147-61. PubMed ID: 1637256
    [Abstract] [Full Text] [Related]

  • 11. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B, Van Tol A, Fruchart JC, Auwerx J.
    Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
    [Abstract] [Full Text] [Related]

  • 12. Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia.
    Sheu WH, Jeng CY, Lee WJ, Lin SY, Pei D, Chen YT.
    Metabolism; 2001 Mar; 50(3):355-9. PubMed ID: 11230791
    [Abstract] [Full Text] [Related]

  • 13. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002 Mar; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 14. [Effects on simvastatin in continuous ambulatory peritoneal dialysis patients with hyperlipidemia].
    Zhu XP, Li J, Liu FY, Liu YH.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr 28; 25(2):154-6. PubMed ID: 12212206
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 28; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 16. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
    Shah B, Nair S, Sirsat RA, Ashavaid TF, Nair KG.
    J Postgrad Med; 1994 Jun 28; 40(2):57-60. PubMed ID: 8737552
    [Abstract] [Full Text] [Related]

  • 17. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C, Basili S, Maurelli M, Andreozzi P, Bracaglia D, Cordova C.
    Clin Ter; 1994 Jan 28; 144(1):3-9. PubMed ID: 8168349
    [Abstract] [Full Text] [Related]

  • 18. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Jan 28; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia.
    de Graaf J, Demacker PN, Stalenhoef AF.
    Neth J Med; 1993 Dec 28; 43(5-6):254-61. PubMed ID: 8107933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.